Tumor Cell Vaccine in Treating Patients With Advanced Cancer

Completed · Phase 2

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Vaccines made from the patient's cancer cells may make the body build an immune response and kill their tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of autologous tumor cell vaccination plus immunologic adjuvant in treating patients who have metastatic cancer.

Key facts

Study ID

NCT00002505

Run by

Hoag Memorial Hospital Presbyterian

Starts

1992-08-01

Expected to finish

2006-05-01

Last updated by the study team

2011-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
• Bloomington Hospital — Bloomington, Indiana, United States
• St. Vincent Hospital and Health Care Center — Indianapolis, Indiana, United States
• Bergan Mercy Medical Center — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.